Latest News for: danah

Edit

Hematology Diagnostics Market is Booming Worldwide | Abbott, Boule Diagnostics, and Danaher are the Major Stakeholders ...

GetNews 02 Apr 2025
Key Vendors Abbott Boule Diagnostics Danaher Diatron Horiba Nihon Kohden Shenzhen Mindray Bio-Medical Electronics Siemens Healthineers Sysmex Alphatec Scientific Agappe Diagnostics Analyticon ...
Edit

Cell therapies: The next generation (Danaher Corporation)

Public Technologies 27 Mar 2025
"The Beacon is a great initiative because it brings together our expertise in gene editing and patient care with Danaher's unique technologies and industry perspective ... Gill and Herbst have received sponsored research funding from Danaher.
Edit

Annual Report (Form ARS) (Danaher Corporation)

Public Technologies 26 Mar 2025
Danaher Corporation published this content on March 26, 2025, and is solely ...
Edit

Additional Proxy Soliciting Materials (Form DEFA14A) (Danaher Corporation)

Public Technologies 26 Mar 2025
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, DC 20549. SCHEDULE 14A ... (Amendment No. ) ... DANAHER CORPORATION ... Danaher Corporation published this content on March 26, 2025, and is solely responsible for the information contained therein.
Edit

2024 Annual Report (Danaher Corporation)

Public Technologies 26 Mar 2025
Danaher ... Danaher ... "2024 marked a significant milestone- Danaher's 40th anniversary ... 2024 marked a significant milestone-Danaher's 40th anniversary ... Danaher is a stronger, better company in 2024 compared with 2019.
Edit

2025 Proxy Statement (Danaher Corporation)

Public Technologies 26 Mar 2025
In this Proxy Statement, the terms "Danaher," the "Company," "we," "us" or "our" refer to Danaher Corporation, Danaher Corporation and its ...
Edit

Proxy Statement (Form DEF 14A) (Danaher Corporation)

Public Technologies 26 Mar 2025
Our Corporate Governance Guidelines make clear that among other criteria required to serve on the Danaher Board, Danaher directors must have availability to devote sufficient time to the affairs of the Company.
Edit

Cell Therapy Technologies Market Report, Growth Forecasts for 2025-2030 and Profiles of Danaher, Merck, Lonza, ...

Nasdaq Globe Newswire 25 Mar 2025
The Cell Therapy Technologies Market was valued at USD 6.54 billion in 2024, and is projected to reach USD 17.46 billion by 2030, rising at a CAGR of 17.84% ... These factors are thus projected to impel the market's growth over the forecast period.
Edit

Danaher Schedules First Quarter 2025 Earnings Conference Call

PR Newswire 20 Mar 2025
The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." ... Explore more at www.danaher.com. SOURCE Danaher Corporation.
  • 1
×